Ian Karp | Senior Vice President-Investor Relations and Corporate Communications |
John Leonard | Chief Executive Officer |
Glenn Goddard | Chief Financial Officer |
David Lebwohl | Chief Medical Officer |
Laura Sepp-Lorenzino | Chief Scientific Officer |
Joon Lee | Truist |
Maury Raycroft | Jefferies |
Greco Song | SVB Leerink |
Swapnil Malekar | Piper Sandler |
Dae Gon Ha | Stifel |
Luca Issi | RBC |
Mike King | H.C. Wainwright |
Ryan Deschner | Raymond James |
Jay Olson | Oppenheimer |
Yanan Zhu | Wells Fargo |
Silvan Tuerkcan | JMP |
Ry Forseth | Guggenheim |
Good morning, and welcome to the Intellia Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. My name is Andrew and I will be your conference operator today.
Following formal remarks, we will open the call up for a question-and-answer session. This conference is being recorded at the company's request and will be available on the company's website following the end of the call.
As a reminder, all participants are currently in listen-only mode.